DNA repair and tumorigenesis - Lessons from hereditary cancer syndromes

被引:86
作者
Heinen, CD [1 ]
Schmutte, H [1 ]
Fishel, R [1 ]
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Genet & Mol Biol Program, Philadelphia, PA 19107 USA
关键词
DNA repair; cancer; apoptosis; cell cycle; checkpoints;
D O I
10.4161/cbt.1.5.160
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The discovery that alterations of the DNA mismatch repair system (MMR) were linked to the common human cancer susceptibility syndrome hereditary nonpolyposis colon cancer (HNPCC) resulted in the declaration of a third class of genes involved in tumor development. In addition to oncogenes and tumor suppressors, alterations of DNA repair genes involved in maintaining genomic stability were found to be a clear cause of turn the level of the single nucleotides or chromosomes. This observation suggested that the establishment of genomic instability, termed the Mutator Phenotype, was an important aspect of tumor development.(1,2) Since the initial identification of the human MutS homolog hMSH2 nearly a decade ago,(3,4) more links have been described between human cancers and genes involved in maintaining genomic stability. Work in-recent years has revealed that DNA repair proteins may also function in signaling pathways that provoke cell cycle arrest and apoptosis. This review will focus on the genetic and biochemical functions of DNA repair genes linked to hereditary cancer predisposition characterized by genomic instability (Table 1). Interestingly, the protein products of these genes have been directly or indirectly linked to the DNA damage-induce cell cycle arrest and apoptosis. We conclude that a robust connection between DNA repair proteins and damage-induced apoptosis may be as important for tumorigenesis as their role in maintaining genome stability.
引用
收藏
页码:477 / 485
页数:9
相关论文
共 117 条
[91]   BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene [J].
Snouwaert, JN ;
Gowen, LC ;
Latour, AM ;
Mohn, AR ;
Xiao, A ;
DiBiase, L ;
Koller, BH .
ONCOGENE, 1999, 18 (55) :7900-7907
[92]  
Spatz A, 2001, CANCER RES, V61, P2480
[93]   The genetics of the hereditary xeroderma pigmentosum syndrome [J].
Stary, A ;
Sarasin, A .
BIOCHIMIE, 2002, 84 (01) :49-60
[94]   The two faces of BRCA2, a FANCtastic discovery [J].
Stewart, G ;
Elledge, SJ .
MOLECULAR CELL, 2002, 10 (01) :2-4
[95]  
Svoboda DL, 1998, CANCER RES, V58, P2445
[96]   Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs [J].
Takata, M ;
Sasaki, MS ;
Tachiiri, S ;
Fukushima, T ;
Sonoda, E ;
Schild, D ;
Thompson, LH ;
Takeda, S .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (08) :2858-2866
[97]   Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways [J].
Taniguchi, T ;
Garcia-Higuera, I ;
Xu, B ;
Andreassen, PR ;
Gregory, RC ;
Kim, ST ;
Lane, WS ;
Kastan, MB ;
D'Andrea, AD .
CELL, 2002, 109 (04) :459-472
[98]   Translocation and reversible localization of signaling proteins: A dynamic future for signal transduction [J].
Teruel, MN ;
Meyer, T .
CELL, 2000, 103 (02) :181-184
[99]   BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines [J].
Thangaraju, M ;
Kaufmann, SH ;
Couch, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33487-33496
[100]   MICROSATELLITE INSTABILITY IN CANCER OF THE PROXIMAL COLON [J].
THIBODEAU, SN ;
BREN, G ;
SCHAID, D .
SCIENCE, 1993, 260 (5109) :816-819